Edwards Training Village at EACTS 2024
Edwards Training Village: Pioneering Excellence in Cardiac Surgery
Eager to elevate your technique? For additional details and registration support, reach out to your Edwards representatives. Spaces are limited, so act quickly!
Thursday 10 Oct 2024
Lifetime management in light of SAPIEN 3 Ultra RESILIA valve
Explore the newest advancements in transcatheter aortic valve technology and techniques, along with lifetime management strategies.
Friday 11 Oct 2024
Lifetime management in light of SAPIEN 3 Ultra RESILIA valve
Explore the newest advancements in transcatheter aortic valve technology and techniques, along with lifetime management strategies.
No clinical data are available that evaluate the long-term impact of RESILIA tissue in patients. Additional clinical data for up to 10 years of follow-up are being collected to monitor the long-term safety and performance of RESILIA tissue.
Refer to device instructions for use for important warnings related to VFit technology. These features have not been observed in clinical studies to establish the safety and effectiveness of the model 11500A for use in ViV procedures. VFit technology is available on sizes 19–25 mm.
Expert opinions, advice and all other information represent contributor’s views and not necessarily those of Edwards Lifesciences.
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult https://eifu.edwards.com where applicable).